Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "Karnataka"

127 News Found

Bayer to set up 27 telemedicine centres across eight states
Sustainability | April 01, 2022

Bayer to set up 27 telemedicine centres across eight states

Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya


Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Seventh international meet on Pharma and MedTech from April 25-27 in New Delhi
News | March 31, 2022

Seventh international meet on Pharma and MedTech from April 25-27 in New Delhi

The event will have a mix of policymakers, national and international leaders from the pharma industry, MSME, innovators, academic and research fraternity


Metropolis recognises medical students with scholarship grants and awards
Diagnostic Center | March 28, 2022

Metropolis recognises medical students with scholarship grants and awards

Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India


Community approach crucial to stamp out diseases
Public Health | March 17, 2022

Community approach crucial to stamp out diseases

The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges


Aster Labs expands across south and west India
Diagnostic Center | March 04, 2022

Aster Labs expands across south and west India

A total of 17 labs will be operational across the country by this month


Experts say extended day prescription refills for hypertension can be a game-changer
Healthcare | February 24, 2022

Experts say extended day prescription refills for hypertension can be a game-changer

The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control


Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment
News | February 11, 2022

Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment

Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad


GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22
News | February 08, 2022

GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22

EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.


AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
News | February 08, 2022

AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.

Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021